Boothbay Fund Management »

Lexeo Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 181k 6.64
2025-06-30 $656k 163k 4.02
2025-03-31 $566k 163k 3.47
2024-12-31 $973k 148k 6.58
2024-09-30 $972k 108k 9.04

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
Vanguard Group
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics